You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Baxter Hlthcare Corp Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?

BAXTER HLTHCARE CORP has sixty-five approved drugs.

There are fifteen US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.

There are eight patent family members on BAXTER HLTHCARE CORP drugs in seven countries and one hundred and twenty-two supplementary protection certificates in fourteen countries.

Summary for Baxter Hlthcare Corp
International Patents:8
US Patents:15
Tradenames:77
Ingredients:51
NDAs:65

Drugs and US Patents for Baxter Hlthcare Corp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp BENDAMUSTINE HYDROCHLORIDE bendamustine hydrochloride SOLUTION;INTRAVENOUS 216078-001 Dec 15, 2022 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078198-002 Jun 30, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp LEVETIRACETAM levetiracetam INJECTABLE;INTRAVENOUS 217059-003 Oct 2, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp FLUMAZENIL flumazenil INJECTABLE;INJECTION 076755-001 Oct 12, 2004 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 214331-001 Sep 17, 2021 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp WYAMINE SULFATE mephentermine sulfate INJECTABLE;INJECTION 008248-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 214792-001 Nov 7, 2022 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Baxter Hlthcare Corp

Supplementary Protection Certificates for Baxter Hlthcare Corp Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1499331 122014000007 Germany ⤷  Try a Trial PRODUCT NAME: NATRIUMSULFAT, MAGNESIUMSULFAT UND KALIUMSULFAT; NAT. REGISTRATION NO/DATE: 86203.00.00 20130808; FIRST REGISTRATION: BELGIEN BE434323 20130220
0107734 93C0042 Belgium ⤷  Try a Trial PROD. NAME TETRAKIS (2-METHOXY-ISOBUTYL-ISONITRILE). CUIVRE (I) TETRAFLUOROBORATE, DIHYDRATE DE CHLORURE STANNEUX, CHLORHYDRATE DE L-CYSTEINE (MONOHYDRATE); REG NO/DATE 923 IS 3 F 12/ 19900924 ; FIRST REG CC NO DATE IE PA 200/9/1 19900817
1534313 122015000111 Germany ⤷  Try a Trial PRODUCT NAME: PHENYLEPHRIN UND KETOROLAC; REGISTRATION NO/DATE: EU/1/15/1018 20150728
1189916 1190003-2.L Sweden ⤷  Try a Trial PRODUCT NAME: REGADENOSON OCH SALTER DAERAV; REG. NO/DATE: EU/1/10/643/001 20100906
1411900 2011C/016 Belgium ⤷  Try a Trial PRODUCT NAME: NAPROXENE ET ESOMEPRAZOLE (SOUS LA FORME D'ESOMEPRAZOLE MAGNESIUM TRIHYDRATE); AUTHORISATION NUMBER AND DATE: BE382505 20101214
1189916 SZ 2/2011 Austria ⤷  Try a Trial PRODUCT NAME: REGADENOSON UND DESSEN SALZE
0521471 SPC/GB03/033 United Kingdom ⤷  Try a Trial PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.